Literature DB >> 16781865

Molecular imaging of thin mammalian tissue sections by mass spectrometry.

Pierre Chaurand1, D Shannon Cornett, Richard M Caprioli.   

Abstract

Imaging of tissue sections by mass spectrometry provides a detailed molecular picture containing information on both the abundance and distribution of many constituent compounds. Mass spectra are acquired directly from fresh frozen tissue sections using matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS); sample preparation and data collection mode determine the spatial resolution or surface area of the section represented in each mass spectrum. Statistical analyses of the individual ion signatures yield biomarkers whose abundances correlate to cell development processes, tumorigenesis and/or drug treatment. In an alternate mode, the generation of intensity maps for individual ions provides a visual representation of the distribution of each species throughout the section at spatial resolutions as small as 50 microm. The availability of this molecular information is likely to be of great value to clinicians and should lead to improved therapeutic efficacy in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781865     DOI: 10.1016/j.copbio.2006.06.002

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  22 in total

1.  From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Dale S Cornett; Peggi M Angel; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2010-08-23       Impact factor: 5.911

2.  Revisiting rat spermatogenesis with MALDI imaging at 20-microm resolution.

Authors:  Mélanie Lagarrigue; Michael Becker; Régis Lavigne; Sören-Oliver Deininger; Axel Walch; Florence Aubry; Detlev Suckau; Charles Pineau
Journal:  Mol Cell Proteomics       Date:  2010-12-12       Impact factor: 5.911

3.  Imaging of phospholipids in formalin fixed rat brain sections by matrix assisted laser desorption/ionization mass spectrometry.

Authors:  Claire L Carter; Cameron W McLeod; Josephine Bunch
Journal:  J Am Soc Mass Spectrom       Date:  2011-09-01       Impact factor: 3.109

Review 4.  Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology.

Authors:  Kristen D Herring; Stacey R Oppenheimer; Richard M Caprioli
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

5.  Through a glass darkly: glimpses into the future of mass spectrometry.

Authors:  R Graham Cooks; Thomas Mueller
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-15

6.  Preparation of single cells for imaging/profiling mass spectrometry.

Authors:  Elena S F Berman; Susan L Fortson; Kyle D Checchi; Ligang Wu; James S Felton; Kuang Jen J Wu; Kristen S Kulp
Journal:  J Am Soc Mass Spectrom       Date:  2008-05-17       Impact factor: 3.109

Review 7.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

Review 8.  Mass spectrometry-based tissue imaging of small molecules.

Authors:  Carly N Ferguson; Joseph W M Fowler; Jonathan F Waxer; Richard A Gatti; Joseph A Loo
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

9.  A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity.

Authors:  Liangran Guo; Irene Panderi; Daisy D Yan; Kevin Szulak; Yajuan Li; Yi-Tzai Chen; Hang Ma; Daniel B Niesen; Navindra Seeram; Aftab Ahmed; Bingfang Yan; Dionysios Pantazatos; Wei Lu
Journal:  ACS Nano       Date:  2013-10-01       Impact factor: 15.881

Review 10.  An introduction to sphingolipid metabolism and analysis by new technologies.

Authors:  Yanfeng Chen; Ying Liu; M Cameron Sullards; Alfred H Merrill
Journal:  Neuromolecular Med       Date:  2010-08-03       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.